Dr Carole Nicco took up her position as CSO of Belgium-based BioSenic in mid-January. Nicco will oversee the development of BioSenic’s cell therapy and autoimmune disease platform pipeline and be responsible for R&D programmes.
https://european-biotechnology.com/wp-content/uploads/2024/04/Eb.com_Carole_Nicco_kl.jpg718639Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-02-06 13:26:002024-07-16 17:26:08BioSenic strengthens scientific team with new CSO